Earnings Call · Q1 FY2026·2026-05-01

Q1 26EPS -2.86%·Rev n/aQ4 25EPS +100.00%*·Rev n/aQ3 25EPS +100.00%*·Rev n/aQ2 25EPS +100.00%*·Rev n/a⚠ consensus missing

Fulgent Genetics, Inc. FLGT

Lauren Sloane — Investor Relations

Ming Hsieh — Chief Executive Officer

Brandon Perthuis — Chief Commercial Officer

Paul Kim — CFO and Treasurer

−7.0%1d on move date−7.3% vs SPY3d−1.9%5d−0.5%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more FLGT calls or request research access.

More FLGT calls Browse calls Request research access